These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19760790)

  • 1. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy.
    Elsheikh B; Prior T; Zhang X; Miller R; Kolb SJ; Moore D; Bradley W; Barohn R; Bryan W; Gelinas D; Iannaccone S; Leshner R; Mendell JR; Mendoza M; Russman B; Smith S; King W; Kissel JT
    Muscle Nerve; 2009 Oct; 40(4):652-6. PubMed ID: 19760790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment for spinal muscular atrophy types II and III.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of the correlation between the clinical phenotype of spinal muscular atrophy and SMN2 gene copy number].
    Lu LP; Ma HW; Jiang J; Wang T; Hu B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):144-7. PubMed ID: 17407069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.
    Wirth B; Brichta L; Schrank B; Lochmüller H; Blick S; Baasner A; Heller R
    Hum Genet; 2006 May; 119(4):422-8. PubMed ID: 16508748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases.
    Calucho M; Bernal S; Alías L; March F; Venceslá A; Rodríguez-Álvarez FJ; Aller E; Fernández RM; Borrego S; Millán JM; Hernández-Chico C; Cuscó I; Fuentes-Prior P; Tizzano EF
    Neuromuscul Disord; 2018 Mar; 28(3):208-215. PubMed ID: 29433793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity.
    Harada Y; Sutomo R; Sadewa AH; Akutsu T; Takeshima Y; Wada H; Matsuo M; Nishio H
    J Neurol; 2002 Sep; 249(9):1211-9. PubMed ID: 12242541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
    Tran VK; Sasongko TH; Hong DD; Hoan NT; Dung VC; Lee MJ; Gunadi ; Takeshima Y; Matsuo M; Nishio H
    Pediatr Int; 2008 Jun; 50(3):346-51. PubMed ID: 18533950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled trial of gabapentin in spinal muscular atrophy.
    Miller RG; Moore DH; Dronsky V; Bradley W; Barohn R; Bryan W; Prior TW; Gelinas DF; Iannaccone S; Kissel J; Leshner R; Mendell J; Mendoza M; Russman B; Samaha F; Smith S;
    J Neurol Sci; 2001 Oct; 191(1-2):127-31. PubMed ID: 11677003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Variability in the Survival Motor Neuron Genes (
    Butchbach MER
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of marker analysis, quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy.
    Alías L; Bernal S; Barceló MJ; Also-Rallo E; Martínez-Hernández R; Rodríguez-Alvarez FJ; Hernández-Chico C; Baiget M; Tizzano EF
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):587-94. PubMed ID: 21548796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural history study of late onset spinal muscular atrophy types 3b and 4.
    Piepers S; van den Berg LH; Brugman F; Scheffer H; Ruiterkamp-Versteeg M; van Engelen BG; Faber CG; de Visser M; van der Pol WL; Wokke JH
    J Neurol; 2008 Sep; 255(9):1400-4. PubMed ID: 18575920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.
    Alves CRR; Zhang R; Johnstone AJ; Garner R; Nwe PH; Siranosian JJ; Swoboda KJ
    Neurology; 2020 Mar; 94(9):e921-e931. PubMed ID: 31882526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.